CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$205,279
-$11,669 QoQ
Shares Held
129,924
+0.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. LCTX ranks #249 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,279 | 129,924 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $216,948 | 129,909 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $368,883 | 218,274 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $62,130 | 68,275 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $226,436 | 503,193 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $208,111 | 416,223 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $378,762 | 416,223 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $416,415 | 416,415 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $541,608 | 365,952 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $395,904 | 363,215 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $428,593 | 363,215 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $512,133 | 363,215 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $102,274 | 68,183 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $53,287 | 45,545 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $51,465 | 45,545 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $71,961 | 45,545 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $511,905 | 332,406 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $772,617 | 315,354 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $794,692 | 315,354 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $918,728 | 322,361 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $113,192 | 48,167 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $116,476 | 66,180 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $62,209 | 66,180 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $57,576 | 66,180 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $193,960 | 233,687 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||